SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

GARCIA MARTINEZ, Montse et al. Evaluación de dos estrategias de cribado de cáncer colorrectal: test inmunológico versus test bioquímico. Cataluña, 2008-2010. Rev. Esp. Salud Publica [online]. 2011, vol.85, n.6, pp. 593-602. ISSN 1135-5727.  http://dx.doi.org/10.1590/S1135-57272011000600008.

    1. Lopez-Abente G, Ardanaz E, Torrella-Ramos A, Mateos A, Delgado-Sanz C, Chirlaque MD. Changes in colorectal cancer incidence and mortality trends in Spain. Ann Oncol. 2010;21 (supl.3):iii76-iii82. [ Links ]

    2. Borrs JM, Pareja L, Peris M, Espins JA. Anlisis de la incidencia, la supervivencia y la mortlidad segn las principales localizaciones tumorales, 1985-2019: cncer colorrectal. Med Clin. 2008;131:58-62. [ Links ]

    3. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765-81. [ Links ]

    4. Recommendations on cancer screening in the European union. Advisory Committee on Cancer Prevention. Eur J Cancer. 2000;36:1473-8. [ Links ]

    5. Council Recommendation of 2 December 2003 on cancer screening. Official J Eur Union 2003; 2003/878/EC: 34-8. [ Links ]

    6. Ministerio de Sanidad y Poltica social. Estrategia en cncer del Sistema Nacional de Salud. Actualizacin aprobada por el Consejo Interterritorial del Sistema Nacional de Salud, el 22 de octubre de 2009. Madrid: Ministerio de Sanidad y Poltica Social; 2010. [ Links ]

    7. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ. 1998;317:559-65. [ Links ]

    8. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103:1541-9. [ Links ]

    9. Quintero E, Andreu M, Lanas A, Piqu JM. Estrategias para la deteccin precoz del cncer colorrectal. En: Bandrs F, Castells A, Morillas JD (coord). La prevencin del cncer colorrectal en Espaa. Alianza para la prevencin del cncer de colon. Madrid: Fundacin Tejerina;2009. [ Links ]

    10. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Segnan N, Patnick J, von Karsa L (eds). European guidelines for quality assurance in colorectal cancer screening and diagnosis-First edition. Luxembourg: European Commission, Publications Office of the European Union;2010. [ Links ]

    11. Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for haemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006;107:2152-9. [ Links ]

    12. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: Update on performance characteristics. J Natl Cancer Inst. 2007;99:1462-70. [ Links ]

    13. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsne D, Boutreux S, et al. Comparison of guaiac-based and immunochemical fecal occult blood test in screening for colorectal cancer in general average-risk population. Gut. 2007;56:210-4. [ Links ]

    14. Fattah AS, Nakama H, Kamijo N, Fujimori K, Zhang B. Colorectal adenomatous polyps detected by immunochemical occult blood screening. Hepatogastroenterology. 1998;45:712-6. [ Links ]

    15. Levi Z, Rozen P, Hazazi R et al. A quantitative inmunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146:244-255. [ Links ]

    16. Segnan N, Senore C, Andreoni B et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology. 2007;132:2304-12. [ Links ]

    17. Peris M, Espinas JA, Munoz L, Navarro M, Binefa G, Borras JM. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screen. 2007;14:81-6. [ Links ]

    18. Jass JR, Sobin LH. Histological typing of intestinal tumors. 2nd ed. New York: Springer, 1989. [ Links ]

    19. Greene FL, Page DL, Fleming ID, Fritz A, Balch DM, Haler DG, et al., editors. AJCC (American Joint Committee on Cancer) Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002. [ Links ]

    20. Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkins W. Colorectal cancer screening: a comparisons of 35 initiatives in 17 countries. Int J Cancer.2008;122:1357-67. [ Links ]

    21. Mlaga A, Salas D, Sala T, Ponce M, Goicoechea M, Andrs M, et al. Programa de cribado de cancer colorrectal de la comunidad valenciana: Resultados de la primera ronda: 2005-2008. Rev Esp Salud Pblica.2010;84:731-43. [ Links ]

    22. Brugos-Llamazares V, Gonzlez de Aledo A, Vada-Snchez J, Tern-Lantarn A. Resultados del programa de deteccion precoz de cancer colorrectal en Cantabria durante el periodo noviembre de 2008 a marzo de 2010. Rev Esp Salud Pblica.2010;84: 757-70. [ Links ]

    23. Ascunce N, Salas D, Zubizarreta R, Almazan R, Ibanez J, Ederra M. Cancer screening in Spain. Ann Oncol. 2010;21 Suppl 3:iii43-iii51. [ Links ]

    24. Nakama H, Zhang B, Zhang X. Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer. Eur J Cancer.2001;37:398-401. [ Links ]

    25. Quintero E. Test qumico o test inmunolgico para la deteccin de sangre oculta en heces en el cribado del cncer colorrectal? Gastroenterol Hepatol.2009;32:565-76. [ Links ]

    26. Ferrndez A, Navarro M, Dez M, Sopena F, Roncals P, Polo-Tomas M, et al. Risk factors for advanced lesions undetected at prior colonoscopy: not always poor preparation. Endoscopy.2010;42:1071-6. [ Links ]

    27. Li S, Wang H, Hu J, Li N, Liu Y, Wu Z, et al. New immunochemical fecal occult blood test with two-consecuitve stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients. Int J Cancer. 2006;118:3078-83. [ Links ]

    28. Parekh M, Fendrick Am, Ladabaum U. As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia. Aliment Pharmacol Ther. 2008;27:697-712. [ Links ]

    29. Berchi C, Bouvier V, Reaud JM, Launoy G. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France. Health Econ.2004;13:227-38. [ Links ]

    30. Sala D. Cribado del cncer colorrectal: fortalezas para avanzar en el cribado en Espaa. Gac Sanit. 2011;25:329-30. [ Links ]